A Pooled Exploratory Analysis of the Effect of Tumor Size and KRAS Mutations on Survival Benefit from Adjuvant Platinum-Based Chemotherapy in Node Negative Non-Small Cell Lung Cancer

Ítems similars

• Pooled Analysis of the Prognostic and Predictive Effects of KRAS Mutation Status and KRAS Mutation Subtype in Early-Stage Resected Non–Small-Cell Lung Cancer in Four Trials of Adjuvant Chemotherapy
  per: Shepherd, Frances A., et al.
  Publicat: (2013)
• Pooled Analysis of the Prognostic and Predictive Effects of TP53 Comutation Status Combined With KRAS or EGFR Mutation in Early-Stage Resected Non–Small-Cell Lung Cancer in Four Trials of Adjuvant Chemotherapy
  per: Shepherd, Frances A., et al.
  Publicat: (2017)
• Prognostic and predictive effect of KRAS gene copy number and mutation status in early stage non-small cell lung cancer patients
  per: Fung, Andrea S., et al.
  Publicat: (2021)
• If Virchow and Ehrlich Had Dreamt Together: What the Future Holds for KRAS-Mutant Lung Cancer
  per: Köhler, Jens, et al.
  Publicat: (2021)
• Genome-wide copy number analyses of samples from LACE-Bio project identify novel prognostic and predictive markers in early stage non-small cell lung cancer
  per: Rotolo, Federico, et al.
  Publicat: (2018)